Common clonal origin of conventional T cells and induced regulatory T cells in breast cancer patientsMore about Open Access at the Crick
Authors listMaria Xydia Raheleh Rahbari Eliana Ruggiero Iain Macaulay Maxime Tarabichi Robert Lohmayer Stefan Wilkening Tillmann Michels Daniel Brown Sebastiaan Vanuytven Svetlana Mastitskaya Sean Laidlaw Niels Grabe Maria Pritsch Raffaele Fronza Klaus Hexel Steffen Schmitt Michael Müller-Steinhardt Niels Halama Christoph Domschke Manfred Schmidt Christof von Kalle Florian Schütz Thierry Voet Philipp Beckhove
Regulatory CD4+ T cells (Treg) prevent tumor clearance by conventional T cells (Tconv) comprising a major obstacle of cancer immune-surveillance. Hitherto, the mechanisms of Treg repertoire formation in human cancers remain largely unclear. Here, we analyze Treg clonal origin in breast cancer patients using T-Cell Receptor and single-cell transcriptome sequencing. While Treg in peripheral blood and breast tumors are clonally distinct, Tconv clones, including tumor-antigen reactive effectors (Teff), are detected in both compartments. Tumor-infiltrating CD4+ cells accumulate into distinct transcriptome clusters, including early activated Tconv, uncommitted Teff, Th1 Teff, suppressive Treg and pro-tumorigenic Treg. Trajectory analysis suggests early activated Tconv differentiation either into Th1 Teff or into suppressive and pro-tumorigenic Treg. Importantly, Tconv, activated Tconv and Treg share highly-expanded clones contributing up to 65% of intratumoral Treg. Here we show that Treg in human breast cancer may considerably stem from antigen-experienced Tconv converting into secondary induced Treg through intratumoral activation.
Journal Nature Communications
Issue number 1